Dilip Shanghvi

{ "bio": [ "The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs.", "The company is India's most valuable listed pharma outfit and gets two-thirds of its $6.1 billion annual revenue from overseas markets.", "He grew Sun through a series of acquisitions, the biggest of which was the 2014 purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion.", "Sun Pharma acquired U.S. skin cancer drug maker Checkpoint Therapeutics in May 2025 for $355 million.", "In February 2025, his son Aalok was appointed as chief operating officer of Sun Pharma." ], "about": [ "Photos of Shanghvi's family deity, Shrinathji, adorn Sun's factories and offices.", "Shanghvi 's favorite cuisine is south Indian.", "In 2023, Sun Pharma completed the $576 million acquisition of U.S.-based Concert Pharmaceuticals." ] }